CareDx (CDNA) Tops Q3 EPS by 2c

CareDx (NASDAQ: CDNA) reported Q3 EPS of ($0.15), $0.02 better than the analyst estimate of ($0.17). Revenue for the quarter came in at $12.2 million versus the consensus estimate of $12.05 million.

GUIDANCE:

CareDx sees Q4 2017 revenue of $47-49 million.

For earnings history and earnings-related data on CareDx (CDNA) click here.

You May Also Be Interested In

• Citigroup (C) Tops Q2 EPS by 42c
• Piper Sandler lifts Halliburton, Patterson-UTI on stronger U.S. land outlook
• IBM misses Q2 targets as mainframe and software sales disappoint